Literature DB >> 19006074

A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand.

J Jacob Strouse1, Susan M Young, Hugh D Mitchell, Richard D Ye, Eric R Prossnitz, Larry A Sklar, Bruce S Edwards.   

Abstract

Formylpeptide receptors (FPRs) are implicated in a variety of immunological and inflammatory response cascades. Further understanding of FPR-family ligand interactions could play an integral role in biological and therapeutic discovery. Fluorescent reporter ligands for the family are desirable experimental tools for increased understanding of ligand/receptor interactions. The ligand binding affinity and fluorescent reporting activity of the peptide WK(FL)YMVm was explored though use of the high throughput HyperCyt flow cytometric platform. Relative binding affinities of several known FPR and FPRL1 peptide ligands were compared in a duplex assay format. The fluorescent W-peptide ligand, WK(FL)YMVm, proved to be a high-affinity, cross-reactive reporter ligand for the FPR/FPRL1 duplex assay. Ligand specificity was demonstrated for each receptor, with known, selective peptide ligands. The binding site specificity of the reporter ligand was further verified by a fluorescent confocal microscopy internalization experiment. The fluorescent peptide ligand WK(FL)YMVm binds with high affinity to both FPR and FPRL1. The differential affinities of known peptide ligands were observed with the use of this fluorescent probe in high throughput screening flow cytometry. 2008 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19006074      PMCID: PMC2917377          DOI: 10.1002/cyto.a.20670

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  39 in total

1.  Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes.

Authors:  Susan M Young; Cristian M Bologa; Dan Fara; Bj K Bryant; Juan Jacob Strouse; Jeffrey B Arterburn; Richard D Ye; Tudor I Oprea; Eric R Prossnitz; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2009-03       Impact factor: 4.355

Review 2.  Microglia and Alzheimer's disease.

Authors:  R N Kalaria
Journal:  Curr Opin Hematol       Date:  1999-01       Impact factor: 3.284

Review 3.  The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function.

Authors:  E R Prossnitz; R D Ye
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

4.  Desensitization of N-formylpeptide receptor-mediated activation is dependent upon receptor phosphorylation.

Authors:  E R Prossnitz
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

5.  Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform.

Authors:  Bruce S Edwards; Susan M Young; Tudor I Oprea; Cristian G Bologa; Eric R Prossnitz; Larry A Sklar
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  Eur J Immunol       Date:  2005-08       Impact factor: 5.532

7.  The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.

Authors:  Emilie Huet; François Boulay; Sophie Barral; Marie-Josèphe Rabiet
Journal:  Cell Signal       Date:  2007-05-29       Impact factor: 4.315

8.  Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.

Authors:  Hui-Xin Wan; Caihong Zhou; Yueyun Zhang; Meiling Sun; Xin Wang; Hong Yu; Xiaoke Yang; Richard D Ye; Jing-Kang Shen; Ming-Wei Wang
Journal:  Biochem Pharmacol       Date:  2007-04-22       Impact factor: 5.858

Review 9.  Biologically active peptides interacting with the G protein-coupled formylpeptide receptor.

Authors:  Yingying Le; Ji Ming Wang; Xiaolei Liu; Yan Kong; Xinwei Hou; Lingfei Ruan; Haiwei Mou
Journal:  Protein Pept Lett       Date:  2007       Impact factor: 1.890

10.  Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.

Authors:  K Gronert; A Gewirtz; J L Madara; C N Serhan
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more
  5 in total

1.  Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Andrei I Khlebnikov; Ni Cheng; Richard D Ye; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2014-10-17       Impact factor: 5.858

Review 2.  Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

Authors:  I A Schepetkin; A I Khlebnikov; M P Giovannoni; L N Kirpotina; A Cilibrizzi; M T Quinn
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

3.  Cluster cytometry for high-capacity bioanalysis.

Authors:  Bruce S Edwards; Jingshu Zhu; Jun Chen; Mark B Carter; David M Thal; John J G Tesmer; Steven W Graves; Larry A Sklar
Journal:  Cytometry A       Date:  2012-03-21       Impact factor: 4.355

Review 4.  Discovery of selective probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30.

Authors:  Jeffrey B Arterburn; Tudor I Oprea; Eric R Prossnitz; Bruce S Edwards; Larry A Sklar
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 5.  The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.

Authors:  Hui-Qiong He; Richard D Ye
Journal:  Molecules       Date:  2017-03-13       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.